CD199 (CCR9), Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CD199 (CCR9), Mouse antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD199 (CCR9), Mouse |
| Clone | REA943 |
| Host Species | Recombinant Human |
| Reactive Species | mouse |
| Isotype | IgG1 |
| Format | allophycocyanin (APC) conjugate |
| Size | 150 µg in 1 mL |
| Concentration | 1:50 |
| Applications | Flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CD199 (CCR9) Antibody, anti-mouse, APC, REAfinity™. Clone REA943 recognizes the mouse CD199 antigen, also known as CCR9. This chemokine receptor for CCL25 (TECK, thymus-expressed chemokine) is a member of the G-protein coupled receptor (GPCR) family. The main function of GPCR family members is to send signals into the cell after the activation of G-proteins. It is reported that CCR9 influences T cell development at several stages within the thymus. Furthermore, in peripheral blood, CCR9 is expressed by naive CD8 T cells, but not by naive CD4 T cells. | Additional information: Clone REA943 displays negligible binding to Fc receptors. |
| Immunogen | n/a |
| Other Names | CCR9, Cmkbr10, GPR-9-6 |
| Gene, Accession # | Gene ID: 12769 |
| Catalog # | 130-115-510 |
| Price | $360 |
| Order / More Info | CD199 (CCR9), Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Zaballos, A. et al. (1999) Cutting Edge: Identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. J Immunol 162 (10): 5671-5675. | Wurbel, M. A. et al. (2006) Complex regulation of CCR9 at multiple discrete stages of T cell development. Eur. J. Immunol. 36 (1): 73-81. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies